Michael Vaiman1, Basel Jabarin2, Rani Abuita2. 1. Department of Otolaryngology - Head and Neck Surgery, Assaf Harofe Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel. Electronic address: vaimed@yahoo.com. 2. Department of Otolaryngology - Head and Neck Surgery, Assaf Harofe Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel.
Abstract
OBJECTIVE: To investigate usefulness of the methylene blue staining for parotid gland surgery. STUDY DESIGN: Randomized, prospective controlled trial. METHODS: The study analyzed 144 surgical operations (2000-2014) for parotidectomy. The cases were randomly divided into two groups: Group 1 (n=70) for surgeries with methylene blue staining, and Group 2 (n=74) for surgeries without staining. Surgical complications like temporary facial weakness, permanent facial nerve injury, and Frey's syndrome were taken for comparison between groups as well as rate of tumor recurrence. RESULTS:Temporary facial weakness and Frey's syndrome occurred almost evenly in both groups (p=0.34, p=0.68 respectively). Permanent facial nerve injury was significantly lower in the group with staining (p=0.032) and the decline of rate of tumor recurrence was even more significant (p=0.007). CONCLUSION: Intravital staining with methylene blue in parotidectomies simplifies the operation and could assist in better visualization that leads to (1) rapid and precise localization of the tumor, (2) preservation of the facial nerve, and (3) complete removal of the gland tissue in cases with malignancy. This technique reduces the rate of recurrence in cases with malignant tumors. LEVEL OF EVIDENCE: 1.
RCT Entities:
OBJECTIVE: To investigate usefulness of the methylene blue staining for parotid gland surgery. STUDY DESIGN: Randomized, prospective controlled trial. METHODS: The study analyzed 144 surgical operations (2000-2014) for parotidectomy. The cases were randomly divided into two groups: Group 1 (n=70) for surgeries with methylene blue staining, and Group 2 (n=74) for surgeries without staining. Surgical complications like temporary facial weakness, permanent facial nerve injury, and Frey's syndrome were taken for comparison between groups as well as rate of tumor recurrence. RESULTS: Temporary facial weakness and Frey's syndrome occurred almost evenly in both groups (p=0.34, p=0.68 respectively). Permanent facial nerve injury was significantly lower in the group with staining (p=0.032) and the decline of rate of tumor recurrence was even more significant (p=0.007). CONCLUSION: Intravital staining with methylene blue in parotidectomies simplifies the operation and could assist in better visualization that leads to (1) rapid and precise localization of the tumor, (2) preservation of the facial nerve, and (3) complete removal of the gland tissue in cases with malignancy. This technique reduces the rate of recurrence in cases with malignant tumors. LEVEL OF EVIDENCE: 1.